The effects of anesthetics on G-protein-coupled receptors

Japanese Journal of Anesthesiology

Volumn 54, Issue 2, 2005, Pages 118-125

  Minami, Kouichiro ^a   Uezono, Yasuhito ^b  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

5 hydroxytryptamine (5 ht; serotonin) receptor; Anesthetic; G protein coupled receptor; Muscarinic receptor; Substance P receptor

Indexed keywords

1,2 DICHLOROHEXAFLUOROCYCLOBUTANE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 4 AMINOBUTYRIC ACID B RECEPTOR; ANESTHETIC AGENT; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE; LIGAND; METABOTROPIC RECEPTOR 5; METHYLSCOPOLAMINE; MUSCARINIC M1 RECEPTOR; PROTEIN KINASE C; RGS PROTEIN; SEROTONIN; SEROTONIN 2A RECEPTOR; SUBSTANCE P RECEPTOR;

CHO CELL; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG TARGETING; HUMAN; NONHUMAN; REVIEW;

ANESTHETICS; HUMANS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, MUSCARINIC; RECEPTORS, NEUROKININ-1; RECEPTORS, SEROTONIN; SIGNAL TRANSDUCTION;

EID: 14944386070     PISSN: 00214892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Caulfield MP. Muscarinic receptors-characterization, coupling and function. Pharmacol Ther 1993; 58: 319-79.
2. Fibiger HC. Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence. Trends Neurosci 1991; 14: 220-3.
3. Durieux ME. Muscarinic signaling in the central nervous system. Recent developments and anesthetic implications. Anesthesiology 1996; 84: 173-89.
4. Eglen RM, Choppin A, Dillon MP, Hegde S. Muscarinic receptor ligands and their therapeutic potential. Curr Opin Chem Biol 1999; 3: 426-32.
5. Wess J. Molecular biology of muscarinic acetylcholine receptors. Crit Rev Neurobiol 1996; 10: 69-99.
6. Wess J, Blin N, Yun J, Schoneberg T, Liu J. Molecular aspects of muscarinic receptor assembly and function. Prog Brain Res 1996; 109: 153-62.
7. Levey AI, Kitt CA, Simonds WF, Price DL, Brann MR. Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. J Neurosci 1991; 11: 3218-26.
8. Anthony BL, Dennison RL, Aronstam RS. Disruption of muscarinic receptor-G protein coupling is a general property of liquid volatile anesthetics. Neurosci Lett 1989; 99: 191-6.
9. + influx and muscarinic receptor-evoked cyclic GMP production in cultured bovine adrenal medullary cells. Naunyn Schmiedebergs Arch Pharmacol 1994; 349: 223-9.
10. Lin LH, Leonard S, Harris RA. Enflurane inhibits the function of mouse and human brain phosphatidylinositol-linked acetylcholine and serotonin receptors expressed in Xenopus oocytes. Mol Pharmacol 1993; 43: 941-8.
11. Durieux ME. Halothane inhibits signaling through m 1 muscarinic receptors expressed in Xenopus oocytes. Anesthesiology 1995; 82: 174-82.
12. Minami K, Vanderah TW, Minami M, Harris RA. Inhibitory effects of anesthetics and ethanol on muscarinic receptors expressed in Xenopus oocytes. Eur J Pharmacol 1997; 339: 237-44.
13. Nietgen GW, Honemann CW, Durieux ME. Influence of anesthetics on endogenous and recombinantly expressed G protein-coupled receptors in the Xenopus oocyte. Toxicol Lett 1998; 100: 319-27.
14. Do SH, Kamatchi GL, Durieux ME. The effects of isoflurane on native and chimeric muscarinic acetylcholine receptors: the role of protein kinase C. Anesth Analg 2001; 93: 375-81.
15. Nietgen GW, Honemann CW, Chan CK, Kamatchi GL, Durieux ME. Volatile anaesthetics have differential effects on recombinant m 1 and m 3 muscarinic acetylcholine receptor function. Br J Anaesth 1998; 81: 569-77.
16. Durieux ME. Inhibition by ketamine of muscarinic acetylcholine receptor function. Anesth Analg 1995; 81: 57-62.
17. Nagase Y, Kaibara M, Uezono Y, Izumi F, Sumikawa K, Taniyama K. Propofol inhibits muscarinic acetylcholine receptor-mediated signal transduction in Xenopus oocytes expressing the rat M 1 receptor. Jpn J Pharmacol 1999; 79: 319-25.
18. Murasaki O, Kaibara M, Nagase Y, Mitarai S, Doi Y, Sumikawa K, et al. Site of action of the general anesthetic propofol in muscarinic M 1 receptor mediated signal transduction. J Pharmacol Exp Ther 2003; 307: 995-1000.
19. Shiraishi M, Minami K, Shibuya I, Uezono Y, Ogata J, Okamoto T, et al. The inhibitory effects of alphaxalone on M 1 and M 3 muscarinic receptors expressed in Xenopus oocytes. Anesth Analg 2003; 97: 449-55.
20. Hollmann MW, Fischer LG, Byford AM, Durieux ME. Local anesthetic inhibition of m 1 muscarinic acetylcholine signaling. Anesthesiology 2000; 93: 497-509.
21. Hollmann MW, Wieczorek KS, Berger A, Durieux ME. Local anesthetic inhibition of G protein-coupled receptor signaling by interference with Galpha(q) protein function. Mol Pharmacol 2001; 59: 294-301.
22. Hollmann MW, Ritter CH, Henle P, de Klaver M, Kamatchi GL, Durieux ME. Inhibition of m 3 muscarinic acetylcholine receptors by local anaesthetics. Br J Pharmacol 2001; 133: 207-16.
23. Eger EI 2nd, Zhang Y, Laster M, Flood P, Kendig JJ, Sonner JM. Acetylcholine receptors do not mediate the immobilization produced by inhaled anesthetics. Anesth Analg 2002; 94: 1500-4.
24. Gyermek L. Pharmacology of serotonin as related to anesthesia. J Clin Anesth 1996; 8: 402-25.
25. Kroeze WK, Kristiansen K, Roth BL. Molecular biology of serotonin receptors structure and function at the molecular level. Curr Top Med Chem 2002; 2: 507-28.
26. Sanna E, Dildy-Mayfield JE, Harris RA. Ethanol inhibits the function of 5-hydroxytryptamine type 1 c and muscarinic M 1 G protein-linked receptors in Xenopus oocytes expressing brain mRNA: role of protein kinase C. Mol Pharmacol 1994; 45: 1004-12.
27. Minami K, Minami M, Harris RA. Inhibition of 5-hydroxytryptamine type 2 A receptor-induced currents by n-alcohols and anesthetics. J Pharmacol Exp Ther 1997; 281: 1136-43.
28. Chapman V, Dickenson AH. The effect of intrathecal administration of RP 67580, a potent neurokinin 1 antagonist on nociceptive transmission in the rat spinal cord. Neurosci Lett 1993; 157: 149-52.
29. De Koninck Y, Henry JL. Substance P-mediated slow excitatory postsynaptic potential elicited in dorsal horn neurons in vivo by noxious stimulation. Proc Natl Acad Sci U S A 1991; 88: 11344-8.
30. Xu XJ, Wiesenfeld-Hallin Z. Intrathecal neurokinin A facilitates the spinal nociceptive flexor reflex evoked by thermal and mechanical stimuli and synergistically interacts with substance P. Acta Physiol Scand 1992; 144: 163-8.
31. Cao YQ, Mantyh PW, Carlson EJ, Gillespie AM, Epstein CJ, Basbaum AI. Primary afferent tachykinins are required to experience moderate to intense pain. Nature 1998; 392: 390-4.
32. Zimmer A, Zimmer AM, Baffi J, Usdin T, Reynolds K, Konig M, et al. Hypoalgesia in mice with a targeted deletion of the tachykinin 1 gene. Proc Natl Acad Sci USA 1998; 95: 2630-5.
33. De Felipe C, Herrero JF, O'Brien JA, Palmer JA, Doyle CA, Smith AJ, et al. Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature 1998; 392: 394-7.
34. Minami K, Shiraishi M, Uezono Y, Ueno S, Shigematsu A. The inhibitory effects of anesthetics and ethanol on substance P receptors expressed in Xenopus oocytes. Anesth Analg 2002; 94: 79-83.
35. Okamoto T, Minami K, Uezono Y, Ogata J, Shiraishi M, Shigematsu A, et al. The inhibitory effects of ketamine and pentobarbital on substance p receptors expressed in Xenopus oocytes. Anesth Analg 2003; 97: 104-10.
36. Kaupmann K, Huggel K, Heid J, Flor PJ, Bischoff S, Mickel SJ, et al. Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors. Nature 1997; 386: 239-46.
37. 2+ signal transduction. J Biol Chem 1992; 267: 13361-8.
38. Conn PJ, Pin JP. Pharmacology and functions of metabotropic glutamate receptors. Ann Rev Pharmacol Toxicol 1997; 37: 205-37.
39. Riedel G. Function of metabotropic glutamate receptors in learning and memory. Trends Neurosci 1996; 19: 219-24.
40. Aiba A, Chen C, Herrup K, Rosenmund C, Stevens CF, Tonegawa S. Reduced hippocampal long-term potentiation and context-specific deficit in associative learning in mGluR 1 mutant mice. Cell 1994; 79: 365-75.
41. Conquet F, Bashir ZI, Davies CH, Daniel H, Ferraguti F, Bordi F, et al. Motor deficit and impairment of synaptic plasticity in mice lacking mGluR 1. Nature 1994; 372: 237-43.
42. Lu YM, Jia Z, Janus C, Henderson JT, Gerlai R, Wojtowicz JM, et al. Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA 1 long-term potentiation (LTP) but normal CA 3 LTP. J Neurosci 1997; 17: 5196-205.
43. Netzeband JG, Gruol DL. Modulatory effects of acute ethanol on metabotropic glutamate responses in cultured Purkinje neurons. Brain Res 1995; 688: 105-13.
44. Smith TL. Selective effects of ethanol exposure on metabotropic glutamate receptor and guanine nucleotide stimulated phospholipase C activity in primary cultures of astrocytes. Alcohol 1994; 11: 405-9.
45. Minami K, Gereau RWt, Minami M, Heinemann SF, Harris RA. Effects of ethanol and anesthetics on type 1 and 5 metabotropic glutamate receptors expressed in Xenopus laevis oocytes. Mol Pharmacol 1998; 53: 148-56.
46. Aronstam RS, Anthony BL, Dennison RL Jr. Halothane effects on muscarinic acetylcholine receptor complexes in rat brain. Biochem Pharmacol 1986; 35: 667-72.
47. Shiraishi M, Minami K, Uezono Y, Yanagihara N, Shigematsu A. Inhibition by tramadol of muscarinic receptor-induced responses in cultured adrenal medullary cells and in Xenopus laevis oocytes expressing cloned M 1 receptors. J Pharmacol Exp Ther 2001; 299: 255-60.
48. Coward P, Chan SD, Wada HG, Humphries GM, Conklin BR. Chimeric G proteins allow a high-throughput signaling assay of Gi-coupled receptors. Anal Biochem 1999; 270: 242-8.
49. Minami K, Uezono Y, Shiraishi M, Okamoto T, Ogata J, Horishita T, Taniyama K, Shigematsu A. Analysis of the effects of halothane on Gi-coupled muscarinic M 2 receptor signaling in Xenopus oocytes using a chimeric Gα protein. Pharmacology 2004; 72: 205-12.
50. Majane EA, Yang HY. Distribution and characterization of two putative endogenous opioid antagonist peptides in bovine brain. Peptides 1987; 8: 657-62.
51. Panula P, Kalso E, Nieminen M, Kontinen VK, Brandt A, Pertovaara A. Neuropeptide FF and modulation of pain. Brain Res 1999; 848: 191-6.
52. Howard AD, McAllister G, Feighner SD, Liu Q, Nargund RP, Van der Ploeg LH, et al. Orphan G-protein-coupled receptors and natural ligand discovery. Trends Pharmacol Sci 2001; 22: 132-40.
53. Kaupmann K, Malitschek B, Schuler V, Heid J, Froestl W, Beck P, et al. GABA (B)-receptor subtypes assemble into functional heteromeric complexes. Nature 1998; 396: 683-7.
54. Jordan BA, Devi LA. G-protein-coupled receptor heterodimerization modulates receptor function. Nature 1999; 399: 697-700.
55. Levac BA, O'Dowd BF, George SR. Oligomerization of opioid receptors: generation of novel signaling units. Curr Opin Pharmacol 2002; 2: 76-81.
56. Acey RA, Bailey S, Healy P, Jo C, Unger TF, Hudson RA. A butyrylcholinesterase in the early development of the brine shrimp (Artemia salina) larvae: a target for phthalate ester embryotoxicity? Biochem Biophys Res Commun 2002; 299: 659-62.
57. Neubig RR, Siderovski DP. Regulators of G-protein signalling as new central nervous system drug targets. Nat Rev Drug Discov 2002; 1: 187-97.
58. Willets JM, Challiss RA, Nahorski SR. Non-visual GRKs: are we seeing the whole picture? Trends Pharmacol Sci 2003; 24: 626-33.